GNLX ($GNLX) Insider Trading & Smart Money Activity

GNLX · Biotechnology · Latest filing Jun 16, 2026

$GNLX has 6 insider trades on file. Insiders filed 6 Form 4 transactions in the last 12 months, none of them open-market purchases or sales.

Insider buyers (12 mo)
0
Insider sellers (12 mo)
0
Net insider $ (12 mo)
$0
Congress trades (12 mo)
0
13F moves on file
0
Analyst ratings on file
0

GNLX insider buying and selling by quarter

QuarterInsider buysInsider salesCongress buys / sales13F added / cut
Q1 2026 0 0 0 / 0 0 / 0
Q2 2026 0 0 0 / 0 0 / 0
Q3 2026 0 0 0 / 0 0 / 0
Q4 2026 0 0 0 / 0 0 / 0

Insider buys and sales count open-market trades only (Form 4 codes P and S). Grants, option exercises and tax withholding are left out.

All GNLX insider, congress, 13F and analyst activity

DateSourceWhoActionSharesValue / amount ΔOwn1W1M6MFilingStory
Insider James Tyree Buy (Grant or award) 31.57K sh -3.6%-6.9% Read
Insider James Tyree Buy (Grant or award) 31.57K sh -3.6%-6.9% Read
Insider John Smither Buy (Grant or award) 31.57K sh -3.6%-6.9% Read
Insider John Smither Buy (Grant or award) 31.57K sh -3.6%-6.9% Read
Insider Mary Mirabelli Buy (Grant or award) 31.57K sh -3.6%-6.9% Read
Insider Mary Mirabelli Buy (Grant or award) 31.57K sh -3.6%-6.9% Read

1W / 1M / 6M = how GNLX moved from the trade or filing date.

Insider trading in GNLX: who is buying and selling

InsiderRoleTradesOpen-market netShares heldLast trade
James Tyree 2 — Jun 16, 2026
John Smither 2 — Jun 16, 2026
Mary Mirabelli 2 — Jun 16, 2026

Frequently asked questions

What is the latest insider trade in GNLX?

James Tyree filed a buy (grant or award) of 31.57K sh on Jun 16, 2026.

Other biotechnology stocks

Data comes from public SEC Form 4 and 13F filings and STOCK Act disclosures. Dates are the trade or filing date reported. This page is for research only and is not investment advice.

Get trade alerts by text